Cargando…
Open Targets Platform: new developments and updates two years on
The Open Targets Platform integrates evidence from genetics, genomics, transcriptomics, drugs, animal models and scientific literature to score and rank target-disease associations for drug target identification. The associations are displayed in an intuitive user interface (https://www.targetvalida...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324073/ https://www.ncbi.nlm.nih.gov/pubmed/30462303 http://dx.doi.org/10.1093/nar/gky1133 |
_version_ | 1783385905238638592 |
---|---|
author | Carvalho-Silva, Denise Pierleoni, Andrea Pignatelli, Miguel Ong, ChuangKee Fumis, Luca Karamanis, Nikiforos Carmona, Miguel Faulconbridge, Adam Hercules, Andrew McAuley, Elaine Miranda, Alfredo Peat, Gareth Spitzer, Michaela Barrett, Jeffrey Hulcoop, David G Papa, Eliseo Koscielny, Gautier Dunham, Ian |
author_facet | Carvalho-Silva, Denise Pierleoni, Andrea Pignatelli, Miguel Ong, ChuangKee Fumis, Luca Karamanis, Nikiforos Carmona, Miguel Faulconbridge, Adam Hercules, Andrew McAuley, Elaine Miranda, Alfredo Peat, Gareth Spitzer, Michaela Barrett, Jeffrey Hulcoop, David G Papa, Eliseo Koscielny, Gautier Dunham, Ian |
author_sort | Carvalho-Silva, Denise |
collection | PubMed |
description | The Open Targets Platform integrates evidence from genetics, genomics, transcriptomics, drugs, animal models and scientific literature to score and rank target-disease associations for drug target identification. The associations are displayed in an intuitive user interface (https://www.targetvalidation.org), and are available through a REST-API (https://api.opentargets.io/v3/platform/docs/swagger-ui) and a bulk download (https://www.targetvalidation.org/downloads/data). In addition to target-disease associations, we also aggregate and display data at the target and disease levels to aid target prioritisation. Since our first publication two years ago, we have made eight releases, added new data sources for target-disease associations, started including causal genetic variants from non genome-wide targeted arrays, added new target and disease annotations, launched new visualisations and improved existing ones and released a new web tool for batch search of up to 200 targets. We have a new URL for the Open Targets Platform REST-API, new REST endpoints and also removed the need for authorisation for API fair use. Here, we present the latest developments of the Open Targets Platform, expanding the evidence and target-disease associations with new and improved data sources, refining data quality, enhancing website usability, and increasing our user base with our training workshops, user support, social media and bioinformatics forum engagement. |
format | Online Article Text |
id | pubmed-6324073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-63240732019-01-10 Open Targets Platform: new developments and updates two years on Carvalho-Silva, Denise Pierleoni, Andrea Pignatelli, Miguel Ong, ChuangKee Fumis, Luca Karamanis, Nikiforos Carmona, Miguel Faulconbridge, Adam Hercules, Andrew McAuley, Elaine Miranda, Alfredo Peat, Gareth Spitzer, Michaela Barrett, Jeffrey Hulcoop, David G Papa, Eliseo Koscielny, Gautier Dunham, Ian Nucleic Acids Res Database Issue The Open Targets Platform integrates evidence from genetics, genomics, transcriptomics, drugs, animal models and scientific literature to score and rank target-disease associations for drug target identification. The associations are displayed in an intuitive user interface (https://www.targetvalidation.org), and are available through a REST-API (https://api.opentargets.io/v3/platform/docs/swagger-ui) and a bulk download (https://www.targetvalidation.org/downloads/data). In addition to target-disease associations, we also aggregate and display data at the target and disease levels to aid target prioritisation. Since our first publication two years ago, we have made eight releases, added new data sources for target-disease associations, started including causal genetic variants from non genome-wide targeted arrays, added new target and disease annotations, launched new visualisations and improved existing ones and released a new web tool for batch search of up to 200 targets. We have a new URL for the Open Targets Platform REST-API, new REST endpoints and also removed the need for authorisation for API fair use. Here, we present the latest developments of the Open Targets Platform, expanding the evidence and target-disease associations with new and improved data sources, refining data quality, enhancing website usability, and increasing our user base with our training workshops, user support, social media and bioinformatics forum engagement. Oxford University Press 2019-01-08 2018-11-20 /pmc/articles/PMC6324073/ /pubmed/30462303 http://dx.doi.org/10.1093/nar/gky1133 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Database Issue Carvalho-Silva, Denise Pierleoni, Andrea Pignatelli, Miguel Ong, ChuangKee Fumis, Luca Karamanis, Nikiforos Carmona, Miguel Faulconbridge, Adam Hercules, Andrew McAuley, Elaine Miranda, Alfredo Peat, Gareth Spitzer, Michaela Barrett, Jeffrey Hulcoop, David G Papa, Eliseo Koscielny, Gautier Dunham, Ian Open Targets Platform: new developments and updates two years on |
title | Open Targets Platform: new developments and updates two years on |
title_full | Open Targets Platform: new developments and updates two years on |
title_fullStr | Open Targets Platform: new developments and updates two years on |
title_full_unstemmed | Open Targets Platform: new developments and updates two years on |
title_short | Open Targets Platform: new developments and updates two years on |
title_sort | open targets platform: new developments and updates two years on |
topic | Database Issue |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324073/ https://www.ncbi.nlm.nih.gov/pubmed/30462303 http://dx.doi.org/10.1093/nar/gky1133 |
work_keys_str_mv | AT carvalhosilvadenise opentargetsplatformnewdevelopmentsandupdatestwoyearson AT pierleoniandrea opentargetsplatformnewdevelopmentsandupdatestwoyearson AT pignatellimiguel opentargetsplatformnewdevelopmentsandupdatestwoyearson AT ongchuangkee opentargetsplatformnewdevelopmentsandupdatestwoyearson AT fumisluca opentargetsplatformnewdevelopmentsandupdatestwoyearson AT karamanisnikiforos opentargetsplatformnewdevelopmentsandupdatestwoyearson AT carmonamiguel opentargetsplatformnewdevelopmentsandupdatestwoyearson AT faulconbridgeadam opentargetsplatformnewdevelopmentsandupdatestwoyearson AT herculesandrew opentargetsplatformnewdevelopmentsandupdatestwoyearson AT mcauleyelaine opentargetsplatformnewdevelopmentsandupdatestwoyearson AT mirandaalfredo opentargetsplatformnewdevelopmentsandupdatestwoyearson AT peatgareth opentargetsplatformnewdevelopmentsandupdatestwoyearson AT spitzermichaela opentargetsplatformnewdevelopmentsandupdatestwoyearson AT barrettjeffrey opentargetsplatformnewdevelopmentsandupdatestwoyearson AT hulcoopdavidg opentargetsplatformnewdevelopmentsandupdatestwoyearson AT papaeliseo opentargetsplatformnewdevelopmentsandupdatestwoyearson AT koscielnygautier opentargetsplatformnewdevelopmentsandupdatestwoyearson AT dunhamian opentargetsplatformnewdevelopmentsandupdatestwoyearson |